We compared the innate immune response to a newly emerged swine-origin influenza A(H3N2) variant containing the M gene from 2009 pandemic influenza A(H1N1), termed "A(H3N2)vpM," to the immune responses to the 2010 swineorigin influenza A(H3N2) variant and seasonal influenza A(H3N2). Our results demonstrated that A(H3N2)vpMinduced myeloid dendritic cells secreted significantly lower levels of type I interferon (IFN) but produced significantly higher levels of proinflammatory cytokines and induced potent inflammasome activation. The reduction in antiviral immunity with increased inflammatory responses upon A (H3N2)vpM infection suggest that these viruses have the potential for increased disease severity in susceptible hosts.
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Swine influenza A(H3N2) emerged in the late 1990s and spread widely in the US swine population. These viruses arose through the introduction of human H3 and N2 genes into swine influenza viruses and subsequent reassortment events that resulted in an internal gene (TRIG) cassette comprising human lineage polymerase basic 1 (PB1) gene, avian lineage polymerase basic 2 (PB2) and polymerase acidic (PA) genes, and swine lineage nucleoprotein (NP), matrix (M), and nonstructural (NS) genes [1] . Until 2011, human infections with this swine-origin, triplereassortant influenza A(H3N2) variant have been sporadic. However, during 2011-2012, 321 human infections with novel A(H3N2) variants possessing the M gene from 2009 pandemic influenza A(H1N1), termed "A(H3N2)vpM," were reported, predominately in children [2, 3] . The M gene from 2009 pandemic influenza A(H1N1) was acquired from the Eurasian swine influenza virus lineage, whose origins are from the Eurasian avian influenza virus lineage. Although there were no reports of community-wide spread of these viruses, animal model studies suggested that the M gene of 2009 pandemic influenza A (H1N1) contributed to the improved transmission efficiency of this virus [4] . In addition to viral determinants, host factors may also contribute to the ability of animal viruses to infect humans. The innate immune system recognizes specific pathogenassociated molecular patterns (PAMPs) in microbial pathogens using pattern-recognition receptors (PRRs) expressed on innate immune cells, especially dendritic cells (DCs), which are professional antigen-presenting cells (APCs) [5] . PRRs respond to PAMPs by triggering the induction of antiviral cytokines, including type I interferon (IFN), and proinflammatory cytokines. Induction of a balanced antiviral and proinflammatory response is crucial to control viral replication and activate optimal adaptive immune responses. Using human peripheral blood mononuclear cells (PBMCs), we show that, unlike seasonal A(H3N2) and A(H3N2) variants, the newly emerging A (H3N2)vpM dampened antiviral cytokine production by myeloid DCs (mDCs) but induced mDCs to produce significantly higher levels of proinflammatory cytokines to prime a mixed T-helper type 1 (Th1)/Th2 responses. The imbalance between antiviral and inflammatory responses was associated with increased virus replication in mDCs.
MATERIALS AND METHODS

Cells
Madin-Darby canine kidney (MDCK) cells were purchased from American Type Culture Collection. Human PBMCs were isolated from citrated blood samples from healthy donors, using Lymphoprep (Stemcell Technologies). Monocytes were isolated from PBMCs by using the human Monocyte Isolation Kit II (Miltenyi biotec). Written informed consent was obtained from all donors and approved by the Centers for Disease Control and Prevention's institutional review board. 
Influenza Viruses
Flow Cytometry Staining
Cells were resuspended in phosphate-buffered saline (PBS) containing 10% fetal bovine serum and stained with following antibodies to analyze DC subsets in PBMCs: CD3-PE-Cy7, CD14-Alexa Fluor 700, CD19-PE-Cy7, CD56-PE-Cy7, CD123-PerCP-Cy5.5, CD11c-APC, and HLA-DR-APC-Cy7 (BD Bioscience). For detection of intracellular cytokines (ICCs), brefeldin A was added into culture in the last 6 hours of incubation. Cells were surface stained with subset markers and made permeable with Cytofix/Cytoperm solution (BD Bioscience). Cells were then stained with following antibodies: interleukin 6 (IL-6)-PE, tumor necrosis factor α (TNF-α)-Pacific Blue, interleukin 1β (IL-1β)-FITC, and interleukin 10 (IL-10)-PE (all from Biolegend) and interleukin 12p40/70 (IL-12p40/70)-PE (Miltenyi Biotech). Samples were analyzed using an LSRII Flow cytometer (BD Biosciences), and the data were analyzed using FlowJo software (Tree Star)
Real-Time Polymerase Chain Reaction (PCR) and Cytokine Detection RNA was isolated using the RNeasy Mini Kit (Qiagen), and complementary DNA (cDNA) was generated using Transcriptor Reverse Transcriptase (Roche Applied Science). Resulting cDNA was diluted 1:5, and 2 µL was used in a SYBR Green (SABioscience)-based real-time PCR reaction, using a Mx3000 real-time PCR instrument (Stratagene). Cytokine and chemokine levels in cell culture supernatants were assayed using enzyme-linked immunosorbent assay kits (IFN-α and IFN-β; PBL biomedical Laboratories) and Pro Human Cytokine 17-plex Assay (Bio-Rad Laboratories).
Immunoblotting and Coimmunoprecipitation
A total 1 × 10 6 of virus-induced DCs were washed with chilled PBS and sonicated in 55 µL of 2X sodium dodecyl sulfate (SDS) sample buffer (20 mM dithiothreitol, 6% SDS, 0.25 M Tris [pH 6.8], 10% glycerol, 10 mM NaF, and bromophenol blue). The extracts were heated at 95°C for 5 minutes. Equal quantities of solubilized protein were resolved by 10% SDSpolyacrylamide gel electrophoresis, blotted to nitrocellulose membrane, and probed with following antibodies: anti-NLRP3 (Nod-like receptor family protein 3; EMD Millipore), anti-ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain), anti-caspase-1, anti-cleaved caspase-1 (Cell Signaling), and anti-β-actin antibody (Sigma-Aldrich . A total of 100 µL of cells was aliquoted into wells of 96-well flat-bottomed white microtiter plates and rested for 20 minutes in incubator. Luminol-012 (Wako) was added at a concentration of 50 µM, followed by 0.3 units of horseradish peroxidase (Sigma). Plates were immediately read using a BioTek plate reader.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 5.0 software (GraphPad Software, La Jolla, California). Groups were compared by 1-way analysis of variance, followed by the Tukey multiple comparison test. Data are presented as mean ± SD. All differences were considered statistically significant when the P value was ≤.05.
RESULTS AND DISCUSSION
We earlier demonstrated that, in response to influenza A virus infection, monocytes rapidly differentiated into mDCs that predominately secreted type I IFN but low amounts of proinflammatory cytokines [6] . to MN/10 and WS/09 ( Figure 1A) . However, while PBMCs infected with MN/10 and those infected with WS/09 secreted moderate levels of proinflammatory cytokines (IL-1β, TNF-α, IL-6, and IL-12p70) and the antiinflammatory cytokine IL-10, the amount of proinflammatory cytokines were remarkably higher in response to IN/11 infection ( Figure 1B) . Further, ICC characterization of the differentiated mDC population demonstrated that a higher proportion of mDCs stimulated with IN/11 produced IL-1, TNF-α, IL-6, IL-12p40/70, and IL-10 as compared to mDCs stimulated with MN/10 and WS/09, which may have contributed to the higher amount of these cytokines in PBMC culture supernatants ( Figure 1C ). Representative data from 1 donor are presented in Figure 1 , and similar findings from additional 4 donors are presented in Supplementary Figure1. Real-time PCR and Bio-plex analyses of in vitrodifferentiated mDCs from monocytes and their culture supernatant further confirmed that IN/11-induced mDCs were potent inducers of inflammatory mediators ( Figure 1D and 1E ). As professional APCs, mDCs secrete different cytokines to skew the T-cell response into 1 or more of the identified + T-cell coculture was assayed by the Bio-Plex assay. G, The viral mRNA expression in mock-infected or virus-infected mDCs from purified monocytes was examined by real-time PCR. H, The mRNA expression of IFN-α and IFN-β in mockinfected or virus-infected mDCs from purified monocytes was examined by real-time RT-PCR. I, The production of IFN-α and IFN-β in mock-induced or virusinduced mDCs from purified monocyte culture supernatants were assayed by ELISA. J, Supernatants from mock-infected or virus-infected mDCs generated from purified monocytes were collected to measure virus titer by the Madin-Darby canine kidney cell-based plaque assay. All data were analyzed using Prism software (GraphPad Software). Data are expressed as means ± SD, and the statistical significance of differences was determined by 1-way analysis of variance, followed by the Tukey multiple comparisons test. P values of <.05 were considered statistically significant. Data are representative of 3 independent experiments. Abbreviations: ELISA, enzyme-linked immunosorbent assay; PFU, plaque-forming units.
types of effector or tolerogenic T cells [7] . The robust level of IL-12p70 and moderate level of IL-10 specifically induced by IN/11-induced mDCs ( Figure 1C-E ) are of importance for Th1 and Th2 polarization, respectively. A mixed lymphocyte reaction confirmed that naive CD4 T cells secreted significantly higher levels of Th1-type cytokines (IFN-γ) and Th2-type cytokines (interleukin 4 and interleukin 5) when cocultured with allogeneic IN/11-induced mDCs from monocytes, compared with CD4 + T cells cocultured with WS/09-and MN/09-induced mDCs ( Figure 1F ) . Collectively, our results demonstrated that A(H3N2)vpM infection led to significantly greater proinflammatory cytokine production to prime a mixed Th1/Th2 response. Next, we examined the production of type I IFN by influenza virus-induced mDCs. Although viral RNA levels indicated similar infection rates ( Figure 1G ), compared with MN/10 and WS/ 09 infection, IN/11 infection resulted in remarkably decreased levels of type I IFN messenger RNA ( Figure 1H ) and protein expression ( Figure 1I ) by mDCs at 16 hours after infection. UV inactivation diminished virus-induced type I IFN production, indicating that replication-competent viruses are required (Supplementary Figure 2 ). In addition, IN/11, compared with WS/09 and MN/10, induced lower levels of IRF3 and IRF7 activation, leading to reduced secretion of type I IFN by virus-induced DCs (Supplementary Figure 3) . Consequently, significantly more viruses were detected in the culture supernatant collected from IN/11-infected mDCs ( Figure 1J ), as well as more viral RNA in infected cells ( Figure 1G ). Our results suggested that, compared with mDCs induced by other A(H3N2) viruses, A(H3N2)vpM-induced mDCs dampened innate antiviral immune responses by suppressing type I IFN production. Oseltamivir treatment before or early in the course of infection remarkably reduced the production of IFN-α but not proinflammatory cytokines (IL-1β and IL-6) by IN/11 (Supplementary Figure 4) .
Induction of increased levels of IL-1β in response to IN/11 infection prompted us to study the mechanism mediating Figure 2 . Influenza A(H3N2)vpM induces potent inflammasome activation through reactive oxygen species (ROS) production. A, The messenger RNA (mRNA) expression of caspase-1 in mock-infected with cells culture medium or virus-infected myeloid dendritic cells (mDCs) was examined by real-time reverse transcription-polymerase change reaction. B, The expression of procaspase-1, caspase-1, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), Nod-like receptor family protein 3 (NLRP3), and β-actin by virus-induced DCs were examined by immunoblotting. Procaspase-1 was immunoprecipitated from mock-induced or virus-induced DCs, and immunoprecipitates (IPs) were analyzed for the presence of NLRP3 and ASC by immunoblotting. C, Interleukin 18 (IL-18) production in supernatants of mock-infected or virus-infected mDCs was examined by enzyme-linked immunosorbent assay (ELISA). D, The production of ROS by mDCs was assayed using the chemiluminescent probe L-012 (50 µM; Wako, Germany). E, Cell lysates of virus-induced mDCs with or without diphenyleneiodonium (DPI) pretreatment were analyzed for procaspase-1, caspase-1, NLRP3, and β-actin expression by immunoblot. F, The production of interleukin 1β (IL-1β) by virus-induced DCs with or without DPI pretreatment was examined by ELISA. All data were analyzed using Prism software (GraphPad Software). Data are expressed as means ± SD, and the statistical significance of differences was determined by 1-way analysis of variance, followed by the Tukey multiple comparisons test. P values of <.05 were considered statistically significant. Data are representative of 3 independent experiments.
IL-1β activation. IL-1β is synthesized as an inactive precursor protein that is cleaved by caspase-1 to release the mature secretory protein [8] . Caspase-1 itself is synthesized as a proenzyme that is cleaved during activation [9] . Interestingly, an increase in caspase-1 messenger RNA was detected upon infection with IN/ 11 and MN/10 but not with WS/09 (Figure 2A ). In mDC cell lysates, comparable levels of procaspase-1 were detected upon mock or virus infection. However, substantially higher expression of caspase-1 was only detected upon IN/11 infection (Figure 2B) . Activation of caspase-1 occurs in the inflammasome following assembly of 3 key proteins: NLRP3, ASC, and procaspase-1 [10] . Consistent with the potent activation of caspase-1, IN/11 infection also induced NLRP3 and ASC activation, as detected by Western blot ( Figure 2B ). Using a coimmunoprecipitation assay, we further demonstrated that NLRP3 or ASC can be coimmunoprecipitated with procaspase-1 from the cell lysate of IN/11-stimulated monocytes stimulated monocytes but not mock-treated monocytes, which suggested inflammasome ternary complex formation upon IN/11 stimulation ( Figure 2B ). IL-1β and caspase-1 are also involved in processing mature interleukin 18 (IL-18) [10] , which has been shown to improve early defense against influenza virus infection [11] . We detected a substantially increased level of IL-18 in culture supernatant of IN/11-infected cells, compared with those from MN/10-infected or WS/09-infected cells ( Figure 2C ). ROS generated in response to several stimuli, including influenza virus infection [12] , are involved in inflammasome activation [13] . We found that IN/11 infection significantly increased ROS levels, as detected using a chemiluminescent probe ( Figure 2D ). Pretreatment for 30 minutes with the ROS inhibitor diphenyleneiodonium (10 µM; Sigma-Aldrich), substantially reduced NLRP3 and caspase-1 activation ( Figure 2E ) and, subsequently, IL-1β secretion in mDCs upon IN/11 infection ( Figure 2F ). Therefore, consistent with previously published observations [14] , our results clearly showed that A(H3N2)vpM induces ROS production, which is required for potent inflammasome activation through the NLRP3-ASC-procaspase-1 interaction, leading to caspase-1 activation and culminating in the generation of IL-1β and IL-18.
M2 derived from A/PR/8/34(H1N1), highly pathogenic influenza virus strains, A/Viet/1194/2004(H5N1), and 1918 Spanish influenza A/Brevig Mission/1/1918(H1N1) has been shown to be sufficient to trigger signal 2 for NLRP3 inflammasome activation [15] , However, introducing the M gene, along with hemagglutinin (HA) and neuraminidase (NA), from 2009 pandemic influenza A (H1N1) into swine A(H3N2) virus (sw/TX/98) did not elevate proinflammatory cytokine production and inflammasome activation (Supplementary Figure 5) , suggesting that the HA and NA from A(H3N2), together with the M2 from 2009 pandemic influenza A(H1N1), are needed for inflammasome activation.
In summary, A(H3N2)vpM infection skewed mDC function from innate antiviral responses to inflammatory responses by suppressing type I IFN production yet promoting proinflammatory cytokine secretion. The altered balance between host antiviral and the inflammatory response induced by A(H3N2)vpMstimulated mDCs suggests that these viruses have the potential for increased disease severity in susceptible hosts.
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